TABLE 14.
Phosphate analogs
Name or abbreviation | Molecular formula | Inhibitory potency (reference) |
---|---|---|
Arsenate | AsO4 | 84% inhibition at 4.6 mM at low conc of phosphate (40 μM) (bovine heart MF1-ATPase) (307) |
Aluminum fluoride | AlF3 and AlF4− | 10 μMa of AlCl3 in the presence of 5 mM NaF and 100 μM ADP (bovine heart MF1-ATPase) (243) |
Beryllium fluoride | BeF+, BeF2, and BeF3− | 10 μMa of BeCl2 in the presence of 5 mM NaF and 100 μM ADP (bovine heart MF1-ATPase) (243); 20 μMa of BeCl2 in the presence of 2.5 mM NaF with 80 μM ADP with 50 mM Cl− (45 min incubation), 20 mM SO42− (14 min incubation), or 20 mM SO3− (2 min incubation) (bovine heart MF1-ATPase) (187) |
Scandium fluoride | ScFx | 60 μMa and 95% inhibition at 0.3 mM in the presence of 2.5 mM MgSO4, 1 mM ADP, and 10 mM NaF (279) |
Vanadate | VO43− and VO3− | VO43−, 50% inhibition in ∼45 min and ∼80% inhibition in ∼2 h at 200 μM in the presence of 200 μM each of MgCl2 and ADP (rat liver MF1-ATPase) (210); VO3−, 30% inhibition at 300 μM (V. parahaemolyticus F1-ATPase) (344) |
Magnesium fluoride | MgFx | 50% inhibition at 1mM NaADP, 1 mM NaF, and 11-12 mM MgCl2 with 5-12 h preincubation (EF1-ATPase) (5) |
Sulfite | SO32− | 3.5 mMa and maximal 70% at 10 mM (P. denitrificans F0F1, ATP synthesis) (295) |
Thiophosphate | SPO33− | Km, 1.5 μM in the presence of 1 mM from 4.5 μM in the absence (pea SMP-ATP synthesis) (254) |
Azide | N3− | ∼10−5 Mb (bovine heart MF1-ATPase) (412); ∼25 μMb (EF1-ATPase) (287); 71% inhibition at 1 mM (V. parahaemolyticus F1-ATPase) (344); >90% inhibition at 0.5 mM (EF1-ATPase) (287); 55% inhibition at 500 μM (C. thermoaceticum F1-ATPase) (190) |
ANPP | C6H4N4O6P | 25 μMa (spinach CF1-ATPase, photoinactivation) (321); 60 μMb in the dark (bovine heart MF1-ATPase) (227) |
I50.
Ki.